Enhanced genome editing in human iPSCs with CRISPR-CAS9 by co-targeting ATP1a1.

Enhanced genome editing in human iPSCs with CRISPR-CAS9 by co-targeting ATP1a1. PeerJ. 2020; 8:e9060.

View in: PubMed